NCp7 And Human Immunodeficiency Virus Drug Development
Share This:
                           

About The Author

Luca Sancineto is a researcher at the Centre of Molecular and Macromolecular Studies in Łódź, Poland. His research interests lie in the development of new and green procedures for oxidation reactions and in the design and synthesis of chalcogen-containing derivatives as metals ligands. Luca Sancineto graduated in 2008 with a bachelor's degree in Pharmacy at the university of Perugia with a comprehensive final grade of summa cum laude. In 2012 he obtained his PhD degree in medicinal chemistry under the supervision of Prof. Oriana Tabarrini and Prof. Violetta Cecchetti, defending a thesis focused on the design and synthesis of novel anti-HIV agents targeting the viral transcriptional machinery.

                       

NCp7 And Human Immunodeficiency Virus Drug Development

Since its identification as the cause of the Acquired ImmunoDeficiency Syndrome (AIDS) in 1983, the Human Immunodeficiency Virus (HIV) has received great attention, and not just from the scientific community. Everybody knows "Philadelphia," that wonderful movie with Tom Hanks and Denzel Washington, or "Dallas Buyers Club," featuring Matthew McConaughey and Jared Leto. These are just a few examples of films dedicated to the AIDS epidemic, a media phenomenon also powered by the deaths of the famous singer Freddy Mercury and...

Read more